Table 2.
Demographic and laboratory results of the euthyroid Hashimoto patients and the control group.
| Euthyroid Hashimoto n = 56 |
Control n = 50 |
P | |
|---|---|---|---|
| Age (mean ± SD) |
36.3 ± 8.11 | 35.42 ± 7.64 | 0.49 |
|
| |||
| TSH (mIU/mL) | 2.39 [IQR: 1.66–3.13] |
1.88 [IQR: 1.46–2.50] |
0.06 |
|
| |||
| FT3 (ng/dL) | 3.19 ± 0.2 | 3.32 ± 0.43 | 0.13 |
|
| |||
| FT4 (ng/dL) | 1.17 [IQR: 1.07–1.23] |
1.20 [IQR: 1.13–1.34] |
0.08 |
|
| |||
| Total-C (mg/dL) | 183.6 ± 31.5 | 176.4 ± 13.6 | 0.04 |
|
| |||
| TG (mg/dL) | 98.5 [IQR: 76.7–140.7] |
81.50 [IQR: 69.7–110.75] |
0.05 |
|
| |||
| HDL-C (mg/dL) | 56.69 ± 11.66 | 54.68 ± 10.96 | 0.32 |
|
| |||
| LDL-C (mg/dL) | 116 [IQR: 102–136.7] |
108.5 [IQR: 97.75–117] |
0.01 |
|
| |||
| Lp(a) (mg/dL) | 17.85 [IQR: 15.5–38.20] |
17.45 [IQR: 10.95–22.02] |
0.94 |
|
| |||
| Excess Lp(a) percent (%) | N = 16 (28%) | N: 6 (12%) | 0.03 |
|
| |||
| BMI (kg/m2) | 25.58 ± 2.72 | 24.9 ± 2.52 | 0.19 |
|
| |||
| HOMA | 1.73 ± 0.55 | 1.59 ± 0.62 | 0.22 |
Normally distributed values are indicated as mean ± SD; nonnormaly distributed values are indicated as median and interquartile ranges.
TSH: thyroid stimulating hormone, FT4: free thyroxin, Total-C: total cholesterol, TG: triglyceride, HDL: high density lipoprotein, LDL: low density lipoprotein, Lp(a): lipoprotein(a), and BMI: body mass index; HOMA for insulin resistance index.
P values are the differences of euthyroid Hashimoto group and control group.